UPDATE: GlobeImmune (GBIM) Reports Q1 Loss Per Share of 15c, Continues to Evaluate Strategic Alternatives

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. CDNS
2. AVGO
3. JBLU
4. ANT
5. META
6. SSD
7. AGYS
8. PECO
9. AMKR
10. BX

Go back to UPDATE: GlobeImmune (GBIM) Reports Q1 Loss Per Share of 15c, Continues to Evaluate Strategic Alternatives

GlobeImmune Announces Updates and Financial Results for First Quarter 2016

May 12, 2016 6:30 AM EDT

LOUISVILLE, CO -- (Marketwired) -- 05/12/16 -- GlobeImmune, Inc. (NASDAQ: GBIM) today provided an update on the Company's business and clinical programs and announced financial results for the first quarter 2016.

The Company continues to seek potential strategic transactions. Cantor Fitzgerald & Co. has been retained by the Company to assist in reviewing ways to maximize stockholder value. There is not a defined timeline for the strategic review process and the review may not result in any specific action or transaction.

The Company has three ongoing clinical... More